Quality Report for Rheumatoid Arthritis

  • This page as PDF


Avalere recently analyzed the quality measure landscape for rheumatoid arthritis.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Rheumatoid arthritis (RA) affects 1.5 million adults aged 18 and older in the U.S. (0.6 percent of the population).1 Avalere identified 53 quality measures that address RA in Avalere’s Quality Measures Navigator®, including seven that are used in the Centers for Medicare & Medicaid Services’ Physician Quality Reporting System program (one of these is also used in the Medicare Advantage (MA) Star Ratings program). Additional outcomes of care measures are needed, including patient-reported outcome measures.

1. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010;62(6):1576-1582

Webinar | Election 2024: What’s at Stake for Healthcare? 

On August 14 at 1:30 PM ET, Avalere experts and guests will discuss the 2024 elections, exploring the candidates’ health policy approaches and implications for stakeholders. 

Learn More

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Quality Improvement
Please enter your email address to be notified when new Quality Improvement insights are published.

Back To Top